Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimum Dose of Vaginal Misoprostol Prior to Office Hysteroscopy: Double Blind Randomized Controlled Trial

NCT01612065 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT01612065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01612065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimum Dose of Vaginal Misoprostol Prior to Office Hysteroscopy: Double Blind Randomized Controlled Trial
Lead sponsor
Cairo University
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2012
Completion date
April 30, 2013
Enrollment
132 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abnormal uterine and vaginal bleeding, unspecified, infertility, recurrent abortion